Method of treatment and compositions comprising a dual pi3k delta-gamma kinase inhibitor and a corticosteroid
AssigneeRhizen Pharmaceuticals SA
InventorsSwaroop K. V. S. VAKKALANKA, Srikant VISWANADHA
Life of this patent
Estimating the term…
Abstract
This present disclosure relates to a method of treating autoimmune, respiratory and/or inflammatory diseases or conditions, e.g., asthma, COPD, rheumatoid arthritis and idiopathic Pulmonary Fibrosis (IPF). The method comprises administering a dual PI3K delta and gamma inhibitor and a corticosteroid. The present invention also relates to pharmaceutical compositions containing a dual PI3K delta and gamma inhibitor and a corticosteroid.
Claims24
A method of treating an autoimmune, respiratory and/or inflammatory disease or condition, the method comprising administering to a subject in need thereof a therapeutically effective amount of (i) a dual PI3K delta and gamma inhibitor, and (ii) a corticosteroid.
A pharmaceutical composition comprising (i) a dual PI3K delta and gamma inhibitor, (ii) a corticosteroid, and (iii) optionally, a pharmaceutically acceptable carrier, glidant, diluent, or excipient.
(canceled)
A kit for treating an autoimmune, respiratory or inflammatory disease or condition, the kit comprising:
- (i) a dual PI3K delta and gamma inhibitor, and (ii) a corticosteroid, or a pharmaceutically acceptable salt thereof, either in a single pharmaceutical composition or in separate pharmaceutical compositions,
- (ii) optionally, instructions for treating the autoimmune, respiratory or inflammatory disease or condition with the dual PI3K delta and gamma inhibitor and corticosteroid and
- (iii) optionally, a container for placing the pharmaceutical composition or pharmaceutical compositions.
Dependencies are inferred from the claim text.